Lack of awareness of risk factors for primary toxoplasmosis in pregnancy

Irish Journal of Medical Science

Volumn 180, Issue 4, 2011, Pages 807-811

  Ferguson, W ^a,b   Mayne, P D ^a,b,c   Cafferkey, M ^a,c   Butler, K ^a,b,c  

^a ROTUNDA HOSPITAL   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Congenital toxoplasmosis; Pregnancy; Risk factors; Toxoplasmosis

Indexed keywords

AMNION FLUID ANALYSIS; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CAT; CLINICAL ARTICLE; CONGENITAL INFECTION; COOKING; FOOD INTAKE; GESTATIONAL AGE; HEALTH EDUCATION; HUMAN; NEWBORN; NEWBORN SCREENING; PREGNANCY; PROSPECTIVE STUDY; RISK FACTOR; THIRD TRIMESTER PREGNANCY; TOXOPLASMA GONDII; TOXOPLASMOSIS; WATER CONTAMINATION;

ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; RISK FACTORS; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; YOUNG ADULT;

EID: 82955233195     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-011-0723-3     Document Type: Article

References (20)

1. W Ferguson PD Mayne B Lennon KM Butler M Cafferkey 2008 Susceptibility of pregnant women to toxoplasma infection-potential benefits for newborn screening IMJ 101 7 220 221 18807815 1:STN:280:DC%2BD1cnhvFCrtQ%3D%3D
2. D Ajzenberg N Cogne L Paris, et al. 2002 Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis and correlation with clinical findings J Infect Dis 186 5 684 689 12195356 10.1086/342663 1:CAS:528:DC%2BD38XnsVSlur0%3D (Pubitemid 34925541)
3. F Peyron JR Lobry K Musset, et al. 2006 Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in South America Microbes Infect 8 9-10 2333 2340 16938480 10.1016/j.micinf.2006.03.023 1:CAS:528:DC%2BD28XhtVGiu7jO (Pubitemid 44499053)
4. FE Leal CL Cavazzana HF de Andrade Jr AJ Galisteo Jr JS de Mendonca EG Kallas 2007 Toxoplasma gondii pneumonia in immunocompetent subjects: case report and review Clin Infect Dis 44 6 e62 e66 17304443 10.1086/511871
5. GN Holland 2003 Ocular toxoplasmosis: a global reassessment. Part 1: Epidemiology and course of disease Am J Ophthalmol 136 6 973 988 14644206 10.1016/j.ajo.2003.09.040 (Pubitemid 37485762)
6. AJ Cook RE Gilbert W Buffolano, et al. 2000 Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis BMJ 321 7254 142 147 10894691 10.1136/bmj.321.7254.142 1:STN:280:DC%2BD3czptFOqtg%3D%3D (Pubitemid 30447005)
7. A Lopez VJ Dietz M Wilson TR Navin JL Jones 2000 Preventing congenital toxoplasmosis MMWR Recomm Rep 49 RR-2 59 68 15580732 1:STN:280: DC%2BD2cngslWksA%3D%3D
8. R McLeod K Boyer T Karrison, et al. 2006 Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study Clin Infect Dis 42 1383 1394 16619149 10.1086/501360
9. AH Havelaar JM Kemmeren LM Kortbeek 2007 Disease burden of congenital toxoplasmosis Clin Infect Dis 44 1467 1474 17479945 10.1086/517511 1:STN:280:DC%2BD2s3nt1yntA%3D%3D (Pubitemid 46801592)
10. M Wallon L Kodjikian C Binquet, et al. 2004 Long-term ocular prognosis in 327 children with congenital toxoplasmosis Paediatrics 113 6 1567 1572 10.1542/peds.113.6.1567 (Pubitemid 38697960)
11. RE Gilbert K Freeman EG Lago, et al. 2008 Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe PLoS Negl Trop Dis 2 8 e277 18698419 10.1371/journal.pntd.0000277
12. JM Pinon H Dumon C Chemla, et al. 2001 Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies J Clin Microbiol 39 6 2267 2271 11376068 10.1128/JCM.39.6.2267-2271. 2001 1:CAS:528:DC%2BD3MXkslCksb8%3D (Pubitemid 32531492)
13. Di Mario S, Basevi V, Gagliotti C et al (2009) Prenatal education for congenital toxoplasmosis. Cochrane Database Syst Rev (Issue 1):Art. No. CD006171. doi: 10.1002/14651858.CD006171.pub2
14. M Breugelmans A Naessens W Foulon 2004 Prevention of toxoplasmosis during pregnancy-an epidemiologic survey over 22 consecutive years J Perinat Med 32 3 211 214 15188792 10.1515/JPM.2004.039 (Pubitemid 38737524)
15. JG Montoya JS Remington 2008 Management of Toxoplasma gondii infection during pregnancy Clin Infect Dis 47 4 554 566 18624630 10.1086/590149
16. Villena I, Ancelle T, Delmas C et al (2010) Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 15(25):pii = 19600. http://www.eurosurveillance.org/ViewArticle.aspx?Articleld= 19600. Accessed 10 Feb 2011
17. JL Jones D Kruszon-Moran M Wilson G Mc Quillan T Navin JB Mc Auley 2001 Toxoplasma gondii infection in the United States: seroprevalence and risk factors Am J Epidemiol 154 4 357 365 11495859 10.1093/aje/154.4.357 1:STN:280:DC%2BD3MvntVGjsg%3D%3D (Pubitemid 32756632)
18. EL Gollub V Leroy R Gilbert G Chene M Wallon 2008 European Toxoprevention Study Group (EUROTOXO). Effectiveness of health education on Toxoplasma related knowledge, behaviour, and risk of seroconversion in pregnancy Eur J Obstet Gynecol Reprod Biol 136 2 137 145 17977641 10.1016/j.ejogrb.2007.09.010 (Pubitemid 351181351)
19. JL Jones A Krueger J Schulkin PM Schantz 2010 Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists Zoonoses Public Health 57 1 27 33 19744302 10.1111/j.1863-2378.2009.01277.x 1:STN:280: DC%2BC3czgtFSgtg%3D%3D
20. The SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thiebaut R, Leproust S, Chene G, Gilbert RE (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369(9556):115-122